Huakang Biomedical Holdings Past Earnings Performance
Past criteria checks 0/6
Huakang Biomedical Holdings's earnings have been declining at an average annual rate of -1.2%, while the Medical Equipment industry saw earnings growing at 14.7% annually. Revenues have been growing at an average rate of 0.8% per year.
Key information
-1.2%
Earnings growth rate
0.6%
EPS growth rate
| Medical Equipment Industry Growth | 13.7% |
| Revenue growth rate | 0.8% |
| Return on equity | -10.8% |
| Net Margin | -24.3% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Huakang Biomedical Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 25 | -6 | 20 | 3 |
| 31 Mar 24 | 25 | -6 | 21 | 3 |
| 31 Dec 23 | 25 | -6 | 20 | 3 |
| 30 Sep 23 | 24 | -5 | 19 | 3 |
| 30 Jun 23 | 25 | -4 | 19 | 3 |
| 31 Mar 23 | 25 | -3 | 19 | 3 |
| 31 Dec 22 | 25 | -3 | 19 | 2 |
| 30 Sep 22 | 26 | -2 | 18 | 3 |
| 30 Jun 22 | 26 | -3 | 18 | 3 |
| 31 Mar 22 | 27 | -4 | 18 | 3 |
| 31 Dec 21 | 26 | -4 | 18 | 2 |
| 30 Sep 21 | 26 | -7 | 18 | 2 |
| 30 Jun 21 | 27 | -8 | 19 | 2 |
| 31 Mar 21 | 25 | -10 | 21 | 2 |
| 31 Dec 20 | 22 | -12 | 21 | 2 |
| 30 Sep 20 | 21 | -9 | 21 | 2 |
| 30 Jun 20 | 21 | -7 | 20 | 2 |
| 31 Mar 20 | 22 | -3 | 18 | 2 |
| 31 Dec 19 | 25 | 0 | 16 | 2 |
| 30 Sep 19 | 26 | -3 | 16 | 2 |
| 30 Jun 19 | 27 | -2 | 14 | 2 |
| 31 Mar 19 | 28 | 0 | 12 | 1 |
| 31 Dec 18 | 29 | 0 | 11 | 1 |
| 31 Dec 17 | 27 | -2 | 6 | 1 |
| 31 Dec 16 | 25 | 8 | 5 | 1 |
| 31 Dec 15 | 19 | 8 | 4 | 2 |
Quality Earnings: 8622 is currently unprofitable.
Growing Profit Margin: 8622 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 8622 is unprofitable, and losses have increased over the past 5 years at a rate of 1.2% per year.
Accelerating Growth: Unable to compare 8622's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 8622 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-4.3%).
Return on Equity
High ROE: 8622 has a negative Return on Equity (-10.81%), as it is currently unprofitable.